Health Service Interventions for Cancer Control in Developing Countries
暂无分享,去创建一个
Joseph Lipscomb | Gerrit Draisma | G. Draisma | S. Goldie | Martin L. Brown | J. Lipscomb | J. Harford | Sue J. Goldie | Joe Harford
[1] L Påhlman,et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.
[2] J. Kievit,et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. , 2003, Journal of the National Cancer Institute.
[3] David K Whynes,et al. Cost-Effectiveness of Screening for Colorectal Cancer: Evidence from the Nottingham Faecal Occult Blood Trial , 2004, Journal of medical screening.
[4] H. Collette,et al. Evaluation of a breast cancer screening programme--the DOM project. , 1992, European journal of cancer.
[5] J. V. van Meerbeeck,et al. Screening and diagnosis of NSCLC. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] R. Hayward,et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.
[7] M. Weinstein,et al. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine , 2003, International journal of cancer.
[8] A. Stiggelbout,et al. Cost-effectiveness analysis of colorectal cancer treatments. , 2002, European journal of cancer.
[9] Daron G Ferris,et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.
[10] P. Roderick,et al. Cost-Effectiveness of Population Screening for Helicobacter Pylori in Preventing Gastric Cancer and Peptic Ulcer Disease, Using Simulation , 2003 .
[11] B. Hillner,et al. Tamoxifen should be cost-effective in reducing breast cancer risk in high-risk women. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] B. Yvonnet,et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. , 1994, Journal of hepatology.
[13] E. Myers,et al. Costs and Effectiveness of Alternative Strategies for Cervical Cancer Screening in Military Beneficiaries , 2002, Obstetrics and gynecology.
[14] T. Wright,et al. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. , 2002, JAMA.
[15] Alan D. Lopez,et al. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 -- Global Burden of Disease and Risk Factors , 2006 .
[16] HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical Cancer , 2000 .
[17] J. Groopman,et al. Translational strategies for cancer prevention in liver , 2003, Nature Reviews Cancer.
[18] Christopher J L Murray,et al. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty , 2003, BMJ : British Medical Journal.
[19] H. D. de Koning,et al. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. , 1995, Journal of the National Cancer Institute.
[20] M. Tockman,et al. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. , 2002, Chest.
[21] F. Sarasin,et al. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. , 1996, The American journal of medicine.
[22] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[23] S. Gallivan,et al. Evaluating cervical cancer screening programmes for developing countries , 1997, International journal of cancer.
[24] H. Koning. Breast cancer screening; cost-effective in practice? , 2000 .
[25] J. Norum,et al. Breast cancer screening by mammography in Norway. Is it cost-effective? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] D. Parkin,et al. Cancer in Africa : epidemiology and prevention , 2003 .
[27] J. Mitchell,et al. A DECISION MODEL AND COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS , 2000, International Journal of Technology Assessment in Health Care.
[28] W. Lawrence,et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. , 2002, Journal of the National Cancer Institute.
[29] D. Coyle,et al. Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.
[30] J. Norum. Adjuvant Cyclophosphamide, Methotrexate, Fluorouracil (CMF) in Breast Cancer: Is it Cost-effective? , 2000, Acta oncologica.
[31] D. Owens,et al. Helicobacter pylori and Gastric Cancer: What Are the Benefits of Screening Only for the CagA Phenotype of H. pylori? , 1999, Helicobacter.
[32] K. Sikora,et al. Essential drugs for cancer therapy: a World Health Organization consultation. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[33] Costa e Silva,et al. Tools for advancing tobacco control in the XXIst century: policy recommendations for smoking cessation and treatment of tobacco dependence: tools for public health. , 2003 .
[34] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[35] John Eng,et al. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. , 2003, JAMA.
[36] L. Coia,et al. The structure of radiation oncology in the United States in 1994. , 1997, International journal of radiation oncology, biology, physics.
[37] I. Johnstone,et al. Helicobacter pylori Eradication and Gastric Preneoplastic Conditions , 2004, Cancer Epidemiology Biomarkers & Prevention.
[38] B. Hillner,et al. The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] P C Prorok,et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. , 2000, Journal of the National Cancer Institute.
[40] M. Brown,et al. Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment. , 1994, Journal of the National Cancer Institute.
[41] T. Wright. Chapter 10: Cervical cancer screening using visualization techniques. , 2003, Journal of the National Cancer Institute. Monographs.
[42] H. D. de Koning,et al. Nationwide breast cancer screening programme fully implemented in The Netherlands. , 2001, Breast.
[43] Martin L. Brown,et al. Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature , 2004, Breast Cancer Research and Treatment.
[44] M H Gail,et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. , 1999, Journal of the National Cancer Institute.
[45] Roberta M Ray,et al. Randomized trial of breast self-examination in Shanghai: final results. , 2002, Journal of the National Cancer Institute.
[46] S. Moss,et al. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. , 1999, Archives of medical research.
[47] Y. Ko,et al. Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[48] M. Fiore,et al. Effective tobacco dependence treatment. , 2002, JAMA.
[49] S Wacholder,et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. , 2000, JAMA.
[50] Shalini L Kulasingam,et al. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. , 2003, JAMA.
[51] D M Parkin,et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors , 1999, International journal of cancer.
[52] J. Sachs. Macroeconomics and health: investing in health for economic development , 2002 .
[53] N. Lee,et al. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. , 2000, Journal of the National Cancer Institute.
[54] Stephen Taplin,et al. Early Detection of Breast Cancer in Countries with Limited Resources , 2003, The breast journal.
[55] T. Powles,et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial , 1998, The Lancet.
[56] James P. Hughes,et al. The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine , 2002, Epidemiology.
[57] Milton C Weinstein,et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. , 2004, Journal of the National Cancer Institute.
[58] D. Parkin,et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China , 2003, Journal of medical screening.
[59] A. Sonnenberg,et al. Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer , 2000, Annals of Internal Medicine.
[60] C. Wheeler,et al. A controlled trial of a human papillomavirus type 16 vaccine. , 2002, The New England journal of medicine.
[61] A. Ezzat,et al. Book review: National cancer control programmes, policies and managerial guidelines. , 1996, Annals of Saudi medicine.
[62] P. Boyle,et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.
[63] A. Hillman,et al. Declining Cost-Effectiveness of Screening for Disease: The Case of Gastric Cancer in Japan , 1995, International Journal of Technology Assessment in Health Care.
[64] D. Alberts,et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. , 2000, The New England journal of medicine.
[65] R. Rajkumar,et al. Effective screening programmes for cervical cancer in low- and middle-income developing countries. , 2001, Bulletin of the World Health Organization.
[66] S. Woolf,et al. Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.
[67] Guilbert Jj. The world health report 2002 - reducing risks, promoting healthy life. , 2003 .
[68] Catherine Legrand. 1687Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) , 2005 .
[69] E. Keeler,et al. Using Cost-Effectiveness Analysis to Define a Breast Cancer Benefits Package for the Uninsured , 2002, Breast Cancer Research and Treatment.
[70] F. Bray,et al. Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.
[71] A. Sabichi,et al. Cancer chemoprevention: progress and promise. , 1998, Journal of the National Cancer Institute.
[72] A. Hall,et al. The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea–Conakry, West Africa , 2002, Journal of gastroenterology and hepatology.
[73] C. Earle,et al. Economic decision analysis model of screening for lung cancer. , 2001, European journal of cancer.
[74] T. Wright,et al. Evaluation of alternative methods of cervical cancer screening for resource‐poor settings , 2000, Cancer.
[75] G J van Oortmarssen,et al. In search of the best upper age limit for breast cancer screening. , 1995, European journal of cancer.
[76] V. Semiglazov,et al. [Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)]. , 1999, Voprosy onkologii.
[77] J D Habbema,et al. A model for breast cancer screening , 1990, Cancer.
[78] T. Wright,et al. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. , 2001, JAMA.
[79] Teresa To,et al. Mammography benefit in the Canadian National Breast Screening Study‐2: A model evaluation , 2004, International Journal of Cancer.
[80] Alan D. Lopez,et al. Global burden of disease and risk factors , 2006 .
[81] Graham A. Colditz,et al. Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.
[82] S. Raab,et al. De novo establishment and cost‐effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam , 2001, Cancer.
[83] A. Mills,et al. Unit costs of health care inputs in low and middle income regions , 2003 .
[84] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[85] Deborah Schrag,et al. The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.
[86] H. D. de Koning,et al. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality , 2004, British Journal of Cancer.
[87] F. Alexander,et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies , 2001, Journal of medical screening.
[88] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[89] Michael Pignone,et al. Cost-Effectiveness Analyses of Colorectal Cancer Screening , 2002, Annals of Internal Medicine.
[90] L. Påhlman,et al. Cost-effectiveness of preoperative radiotherapy in rectal cancer: results from the Swedish Rectal Cancer Trial. , 2002, International journal of radiation oncology, biology, physics.
[91] P. Rose,et al. Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: implications from five randomized trials. , 2000, Gynecologic oncology.
[92] T. Imperiale. Aspirin and the prevention of colorectal cancer. , 2003, The New England journal of medicine.
[93] H. Gurney,et al. A cost‐utility approach to the use of 5‐fluorouracil and levamisole as adjuvant chemotherapy for Dukes’ C colonic carcinoma , 1993 .
[94] J. Weissfeld,et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. , 2000, The New England journal of medicine.
[95] E. Frodis,et al. Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme , 2000, Journal of medical screening.
[96] D. Jamison,et al. Disease Control Priorities in Developing Countries , 1993 .
[97] H. Whittle,et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. , 1999, Vaccine.
[98] Mireille J. M. Broeders,et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines , 1998 .
[99] Gillian D. Sanders,et al. Cost Effectiveness of a Potential Vaccine for Human papillomavirus , 2003, Emerging infectious diseases.
[100] B. Thomadsen,et al. Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study. , 2003, International journal of radiation oncology, biology, physics.
[101] K. Simpson,et al. Informing the Mammography Coverage Debate: Results of Meta-analysis, Computer Modeling, and Issue Analysis , 1991, International Journal of Technology Assessment in Health Care.
[102] L. Marks,et al. Assessing the cost-effectiveness of postmastectomy radiation therapy. , 1999, International journal of radiation oncology, biology, physics.
[103] H. Glick,et al. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[104] P. Singer,et al. Quality end-of-life care: A global perspective , 2002, BMC palliative care.
[105] T. Wright,et al. Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More , 2004, Obstetrics and gynecology.